LTFS
MDGL icon

Ladenburg Thalmann Financial Services’s Madrigal Pharmaceuticals MDGL Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$4K Hold
47
– – ﹤0.01% 4865
2019
Q3 		$4K Buy
47
+20
+74% +$1.88K ﹤0.01% 4775
2019
Q2 		$3K Sell
27
-200
-88% -$21.4K ﹤0.01% 4881
2019
Q1 		$28K Hold
227
– – ﹤0.01% 3799
2018
Q4 		$25K Hold
227
– – ﹤0.01% 3729
2018
Q3 		$48K Sell
227
-525
-70% -$132K ﹤0.01% 3339
2018
Q2 		$88K Hold
752
– – ﹤0.01% 2828
2018
Q1 		$88K Buy
752
+700
+1,346% +$86.4K ﹤0.01% 2828
2017
Q4 		$5K Hold
52
– – ﹤0.01% 4517
2017
Q3 		$2K Hold
52
– – ﹤0.01% 4678
2017
Q2 		$1K Hold
52
– – ﹤0.01% 4743
2017
Q1 		$1K Sell
52
-28
-35% -$440 ﹤0.01% 4721
2016
Q4 		$1K Hold
80
– – ﹤0.01% 4675
2016
Q3 		$1K Sell
80
-1
-1% -$10 ﹤0.01% 4628
2016
Q2 		$0 Hold
81
– – ﹤0.01% 4795
2016
Q1 		$0 Buy
81
+28
+53% +$234 ﹤0.01% 4748
2015
Q4 		$1K Buy
53
+43
+430% +$1.18K ﹤0.01% 4523
2015
Q3 		$1K Hold
10
– – ﹤0.01% 4431
2015
Q2 		$1K Sell
10
-57
-85% -$4.78K ﹤0.01% 4502
2015
Q1 		$5K Buy
67
+10
+18% +$858 ﹤0.01% 3979
2014
Q4 		$5K Sell
57
-2
-3% -$207 ﹤0.01% 3739
2014
Q3 		$6K Hold
59
– – ﹤0.01% 3328
2014
Q2 		$8K Buy
59
+2
+4% +$292 ﹤0.01% 3190
2014
Q1 		$9K Hold
57
– – ﹤0.01% 3014
2013
Q4 		$10K Sell
57
-57
-50% -$10.4K ﹤0.01% 2933
2013
Q3 		$25K Buy
+114
New +$24.3K ﹤0.01% 2296

Other funds holding MDGL

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Ladenburg Thalmann Financial Services's MDGL Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services held its Madrigal Pharmaceuticals (MDGL) position steady in Q4 2019 at 47 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #4865.

Ladenburg Thalmann Financial Services first reported a position in MDGL in Q3 2013 and has held it in 26 quarters since. The position peaked at $88K in Q2 2018. 120 funds tracked by Wall St. Rank hold MDGL as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 47 shares of Madrigal Pharmaceuticals worth $4K as of Q4 2019.
  • Ladenburg Thalmann Financial Services left its Madrigal Pharmaceuticals share count unchanged in Q4 2019.
  • Madrigal Pharmaceuticals made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #4865 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Madrigal Pharmaceuticals in Q3 2013 and has held it in 26 quarters since.
  • Ladenburg Thalmann Financial Services's Madrigal Pharmaceuticals position peaked at $88K in Q2 2018.
  • 120 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.